Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02704130 · ClinicalTrials.gov registry record · NA
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02704130: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.
NCT02704130 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02704130, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This is a single-center, prospective RCT to study the effectiveness of TACE and MWA combination therapy with MWA monotherapy for the treatment of early HCC. Primary outcome is 2-year intrahepatic disease-free survival.
Primary Outcome
Defined as the absence of local or regional recurrence of hepatocellular carcinoma (HCC) as determined by diagnostic imaging
Interventions
- PROCEDURE Microwave Ablation
- DEVICE Transarterial embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-01 |
| Phase | NA |
Why NCT02704130 stopped before completion
NCT02704130 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Microwave Ablation is the first listed.
NCT02704130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02704130 about?
NCT02704130 is a clinical study titled "TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma". This is a single-center, prospective RCT to study the effectiveness of TACE and MWA combination therapy with MWA monotherapy for the treatment of early HCC. Primary outcome is 2-year intrahepatic disease-free survival.
What is the current status of trial NCT02704130?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2016-03. Estimated completion is 2018-01.
What interventions are being tested in trial NCT02704130?
The interventions under investigation include: Microwave Ablation (PROCEDURE), Transarterial embolization (DEVICE).
Who is sponsoring clinical trial NCT02704130?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02704130's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia